CWBR CohBar is a clinical stage biotechnology company which develops mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. CWBR closed few months ago a $15.0 Million Offering of Common Stock and Warrants at $0.72, so this is a safe upside in my opinion if you want to enter now. Cantor Fitzgerald brokerage has a $2.5...
There is a good deal more economic news on tap this week with a jobs report Friday and PMIs mid-week. Earnings continue with 25% of the S&P still left to report. Beyond my favorites futures contracts which include stock indices, interest rates, and metals, I'll be watching the Chinese stocks and what Bitcoin wants to do around $40K.
MBT has been stuck in a downtrend since 2006, a continuation of this downtrend is most likely. However rising MACD shows promise, it may be rejected as seen before (highlighted in blue box) Gaussian channel shows a possible rejection at the middle. Blue line shows a rounded bottom which is another bullish sign, however it looks particularly bearish in these...
We've been monitoring the action in shares of MOBILE TELESYSTEMS - NYSE:MBT for a while now and it appears that the stock is starting to find buyers as it approaches a significant level in order for the stock to release into higher ground. As we can witness from the Daily chart above, MBT presently finds itself trading above all of its important moving...
Shares of DSKX continues to rally from last week after they held a conference call to discuss the recently announced agreement to acquire Radiancy, Inc., a leading developer of consumer medical devices and the Neova® dermatological products. It appears investors are beginning to notice the financial value this new deal brings and the future outlook of the company,...